Literature DB >> 2785014

Degradation of laminin by human tumor cathepsin B.

T T Lah1, M R Buck, K V Honn, J D Crissman, N C Rao, L A Liotta, B F Sloane.   

Abstract

Cathepsin B activity, including that of a plasma membrane-associated cathepsin B, has been linked to tumor malignancy. As cathepsin B at the tumor cell surface has been hypothesized to play a role in the focal degradation of basement membrane during the metastatic cascade, we have examined the ability of human tumor cathepsin B to degrade laminin, an adhesive glycoprotein found exclusively in the basement membrane. We report that at pH 6.5 and 7.0 tumor cathepsin B degraded by specific, limited proteolysis both subunits of native laminin. The disappearance of both subunits and the appearance of lower Mr protein bands could be observed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Accumulation of degradation products was also observed using gel filtration chromatography and a fluorescamine assay. The proteolysis of laminin by tumor cathepsin B could be inhibited by an active site titrant for cysteine proteinases or stefin B, an endogenous low-Mr cysteine proteinase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785014     DOI: 10.1007/bf01753666

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  17 in total

1.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Cell surface interactions with extracellular materials.

Authors:  K M Yamada
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

Review 4.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.

Authors:  R E Ryan; J D Crissman; K V Honn; B F Sloane
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  Cystatin-like cysteine proteinase inhibitors from human liver.

Authors:  G D Green; A A Kembhavi; M E Davies; A J Barrett
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

7.  Characterization of a latent cysteine proteinase from ascitic fluid as a high molecular weight form of cathepsin B.

Authors:  J S Mort; M S Leduc; A D Recklies
Journal:  Biochim Biophys Acta       Date:  1983-02-22

8.  Cathepsin B: association with plasma membrane in metastatic tumors.

Authors:  B F Sloane; J Rozhin; K Johnson; H Taylor; J D Crissman; K V Honn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  Cystatin, a protein inhibitor of cysteine proteinases. Improved purification from egg white, characterization, and detection in chicken serum.

Authors:  A Anastasi; M A Brown; A A Kembhavi; M J Nicklin; C A Sayers; D C Sunter; A J Barrett
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

10.  Effect of ovarian hormones on lysosomal acid hydrolase activities in rat myometrium.

Authors:  B F Sloane; J W Bird
Journal:  Am J Physiol       Date:  1977-04
View more
  21 in total

Review 1.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

2.  Inflammatory Monocytes Promote Perineural Invasion via CCL2-Mediated Recruitment and Cathepsin B Expression.

Authors:  Richard L Bakst; Huizhong Xiong; Chun-Hao Chen; Sylvie Deborde; Anna Lyubchik; Yi Zhou; Shizhi He; William McNamara; Sei-Young Lee; Oakley C Olson; Ingrid M Leiner; Andrea R Marcadis; James W Keith; Hikmat A Al-Ahmadie; Nora Katabi; Ziv Gil; Efsevia Vakiani; Johanna A Joyce; Eric Pamer; Richard J Wong
Journal:  Cancer Res       Date:  2017-09-26       Impact factor: 12.701

Review 3.  Cathepsin B and its endogenous inhibitors: the role in tumor malignancy.

Authors:  B F Sloane; K Moin; E Krepela; J Rozhin
Journal:  Cancer Metastasis Rev       Date:  1990-12       Impact factor: 9.264

4.  Human tumour cathepsin B. Comparison with normal liver cathepsin B.

Authors:  K Moin; N A Day; M Sameni; S Hasnain; T Hirama; B F Sloane
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

Review 5.  Lysosomal enzymes, cathepsins in brain tumour invasion.

Authors:  Natasa Levicar; Tadej Strojnik; Janko Kos; Ricardo A Dewey; Geoffrey J Pilkington; Tamara T Lah
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

6.  IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.

Authors:  Vasilena Gocheva; Hao-Wei Wang; Bedrick B Gadea; Tanaya Shree; Karen E Hunter; Alfred L Garfall; Tara Berman; Johanna A Joyce
Journal:  Genes Dev       Date:  2010-01-15       Impact factor: 11.361

7.  Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues.

Authors:  M R Buck; D G Karustis; N A Day; K V Honn; B F Sloane
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

8.  Cathepsin B expression in tumour cells and laminin distribution in pulmonary adenocarcinoma.

Authors:  M Higashiyama; O Doi; K Kodama; H Yokouchi; R Tateishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

9.  Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.

Authors:  Stefan Tholen; Martin L Biniossek; Martina Gansz; Theresa D Ahrens; Manuel Schlimpert; Jayachandran N Kizhakkedathu; Thomas Reinheckel; Oliver Schilling
Journal:  Cell Mol Life Sci       Date:  2013-06-29       Impact factor: 9.261

10.  Cystatin C is downregulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways.

Authors:  Barbara Wegiel; Thomas Jiborn; Magnus Abrahamson; Leszek Helczynski; Leo Otterbein; Jenny Liao Persson; Anders Bjartell
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.